Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.1K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

491
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
491
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

861
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
861
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

1.2K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

360
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during Glomerulonephritis.

Journal of immunology (Baltimore, Md. : 1950)·2021
Same author

Gram-positive anaerobe cocci are underrepresented in the microbiome of filaggrin-deficient human skin.

The Journal of allergy and clinical immunology·2016
Same author

Dysregulation of proinflammatory versus anti-inflammatory human T<sub>H</sub>17 cell functionalities in the autoinflammatory Schnitzler syndrome.

The Journal of allergy and clinical immunology·2016
Same author

The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.

Arthritis research & therapy·2015
Same author

Absent in Melanoma 2 is predominantly present in primary melanoma and primary squamous cell carcinoma, but largely absent in metastases of both tumors.

Journal of the American Academy of Dermatology·2014
Same author

Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome.

The Journal of allergy and clinical immunology·2014

Related Experiment Video

Updated: Apr 14, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.7K

Schnitzler's syndrome: lessons from 281 cases.

Heleen D de Koning1

  • 1Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands ; Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands ; Nijmegen Center for Immunodeficiency and Autoinflammation, Nijmegen, The Netherlands.

Clinical and Translational Allergy
|April 24, 2015
PubMed
Summary

Schnitzler syndrome is a rare autoinflammatory disease. This review details its clinical features, treatments, and pathogenesis, highlighting interleukin-1 beta's role in this condition.

Keywords:
AutoinflammationChronic urticariaInterleukin-1 betaMonoclonal gammopathyParaproteinSchnitzler’s syndrome

Related Experiment Videos

Last Updated: Apr 14, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.7K

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Background:

  • Schnitzler syndrome is an autoinflammatory disorder.
  • It is characterized by monoclonal gammopathy, chronic urticarial rash, and systemic inflammation.
  • First described in 1972, it affects approximately 281 reported cases.

Purpose of the Study:

  • To review the clinical features of Schnitzler syndrome.
  • To evaluate the efficacy of various therapies.
  • To discuss the pathogenesis, including the role of interleukin-1 beta.

Main Methods:

  • Systematic review of 281 reported cases.
  • Analysis of clinical features, treatment outcomes, and follow-up data.
  • Review of skin histology, bone imaging, laboratory findings, and pathogenetic studies.

Main Results:

  • The review synthesizes data on clinical presentation, treatment efficacy, and long-term outcomes.
  • Pathogenesis is explored, emphasizing the significant role of interleukin-1 beta.
  • Diagnostic and therapeutic strategies are discussed based on available evidence.

Conclusions:

  • Schnitzler syndrome requires comprehensive understanding for effective management.
  • Interleukin-1 beta is a key factor in the disorder's pathogenesis.
  • Further research is needed to optimize treatment and understand long-term prognosis.